Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now     
Bio B2BOrient Pharma Co., Ltd. 〉Zulitor Tablets 4mg

Zulitor Tablets 4mg

Zulitor Tablets 4mg

1. Effective in treating dyslipidemia
3. Better choice for patients with Type 2 Diabetes
4. Decrease cardiovascular events
5. Renal protection
6. Safe

Request for Collaboration
Overview
  • Pitavastatin is a new statin for treating dyslipidemia. It is a better choice for patient with Type 2 Diabetes and it provides benefits for decreasing cardiovascular events.
  • Zulitor Tablets 4mg was launched in Taiwan in 2016 and is under registration in South East Asia. Orient Pharma challenges Paragraph IV of ANDA and the application was accepted by US FDA.
Features
1. Effective for decreasing LDL-C levels in patients with dyslipidemia
2. Greater effect on elevation of HDL-C
3. Neutral effect on HbA1c and blood sugar control of Type 2 diabetes patients
4. Beneficial for atherosclerosis and decrease CV events
5. Renal protection effect by eGFR elevation
6. Unique Safety Profile
Specifications
Zulitor Tablets 4mg (Pitavastatin)
Application
Dyslipidemia
Collaboration Options
Open for collaboration
People who like this also like
  • Pemetrexed Lyo Inj.Pemetrexed Lyo Inj.
  • LansoprazoleLansoprazole
  • Sentinel FMDV NSP Ab ELISA kit (for Livestock)Sentinel FMDV NSP Ab ELISA kit (for Livestock)
  • Neuro-trition-Hericium erinaceusNeuro-trition-Hericium erinaceus
  • Healthcare Genetic TestingHealthcare Genetic Testing
  • Buno Nasal AQUABuno Nasal AQUA
  • PAX1 DNA Detection KitPAX1 DNA Detection Kit
  • NatoCleanseNatoCleanse
  • U2™ HA StemU2™ HA Stem
  • Facial Dermal ImplantFacial Dermal Implant